Professor Carmel Hawley
Professor

Carmel Hawley

Email: 

Background

Carmel Hawley MBBS, FRACP, M.Med.Sci, is a Senior Staff Specialist and Director of Haemodialysis Services at Princess Alexandra Hospital. In addition, she is an Associate Professor (A/P) of Medicine at the School of Medicine, University of Queensland and current (inaugural) Chair for the Australasian Kidney Trials network (AKTN) formed in 2005. Under A/P Hawley’s stewardship, AKTN’s research output is now recognised internationally for its quality and impact. This has driven major advances in the evidence base, that directly informs care and outcomes for people living with chronic kidney disease. A/P Hawley also holds a Master’s degree in Biostatistics, has expertise in trial management, methodology, design and conduct. She is currently involved in numerous industry-led and/or investigator initiated international and national clinical trials as either a Principal or Associate Investigator, providing leadership and direction to emerging early and mid-career researchers.

Availability

Professor Carmel Hawley is:
Available for supervision
Media expert

Fields of research

Clinical sciences

Qualifications

  • Bachelor of Medicine and Surgery and Medical Science, The University of Queensland
  • Masters (Coursework), Institution to be confirmed
  • Royal Australasian College of Physicians, Royal Australasian College of Physicians

Research interests

  • Chronic Kidney Disease

  • Kidney Transplant

  • Kidney Dialysis

  • Kidney Clinical Trials

Search Professor Carmel Hawley’s works on UQ eSpace

721 works between 1965 and 2025
All (721) Journal Article (490) Conference Publication (225) Book Chapter (6)

341 - 360 of 721 works

2015

Journal Article

Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease

Lo, Clement, Toyama, Tadashi, Hirakawa, Yoichiro, Jun, Min, Cass, Alan, Hawley, Carmel, Pilmore, Helen, Badve, Sunil V., Perkovic, Vlado and Zoungas, Sophia (2015). Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease. Cochrane Database of Systematic Reviews, 2015 (8) CD011798. doi: 10.1002/14651858.CD011798

Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease

2015

Journal Article

Research Priorities in CKD: Report of a National Workshop Conducted in Australia

Tong, Allison, Crowe, Sally, Chando, Shingisai, Cass, Alan, Chadban, Steve J, Chapman, Jeremy R, Gallagher, Martin, Hawley, Carmel M, Hill, Sophie, Howard, Kirsten, Johnson, David W, Kerr, Peter G, McKenzie, Anne, Parker, David, Perkovic, Vlado, Polkinghorne, Kevan R, Pollock, Carol, Strippoli, Giovanni F.M, Tugwell, Peter, Walker, Rowan G, Webster, Angela C, Wong, Germaine and Craig, Jonathan C (2015). Research Priorities in CKD: Report of a National Workshop Conducted in Australia. American Journal of Kidney Diseases, 66 (2), 212-222. doi: 10.1053/j.ajkd.2015.02.341

Research Priorities in CKD: Report of a National Workshop Conducted in Australia

2015

Journal Article

Left ventricular global longitudinal strain is associated with cardiovascular risk factors and arterial stiffness in chronic kidney disease

Krishnasamy, Rathika, Hawley, Carmel M., Stanton, Tony, Pascoe, Elaine M., Campbell, Katrina L., Rossi, Megan, Petchey, William, Tan, Ken-Soon, Beetham, Kassia S., Coombes, Jeff S., Leano, Rodel, Haluska, Brian A. and Isbel, Nicole M. (2015). Left ventricular global longitudinal strain is associated with cardiovascular risk factors and arterial stiffness in chronic kidney disease. BMC Nephrology, 16 (106) 106, 1-9. doi: 10.1186/s12882-015-0098-1

Left ventricular global longitudinal strain is associated with cardiovascular risk factors and arterial stiffness in chronic kidney disease

2015

Journal Article

Socio-economic status and peritonitis in Australian non-indigenous peritoneal dialysis patients

Tang, Wen, Grace, Blair, McDonald, Stephen P., Hawley, Carmel M., Badve, Sunil V., Boudville, Neil C., Brown, Fiona G., Clayton, Philip A. and Johnson, David W. (2015). Socio-economic status and peritonitis in Australian non-indigenous peritoneal dialysis patients. Peritoneal Dialysis International, 35 (4), 450-459. doi: 10.3747/pdi.2013.00004

Socio-economic status and peritonitis in Australian non-indigenous peritoneal dialysis patients

2015

Journal Article

The omega-3 fatty acids (fish oils) and aspirin in Vascular access outcomes in renal disease (FAVOURED) study: the updated final trial protocol and rationale of post-initiation trial modifications

Viecelli, Andrea K., Pascoe, Elaine, Polkinghorne, Kevan R., Hawley, Carmel, Paul-Brent, Peta-Anne, Badve, Sunil V., Cass, Alan, Heritier, Stephane, Kerr, Peter G., Mori, Trevor A., Robertson, Amanda, Seong, Hooi L. and Irish, Ashley B. (2015). The omega-3 fatty acids (fish oils) and aspirin in Vascular access outcomes in renal disease (FAVOURED) study: the updated final trial protocol and rationale of post-initiation trial modifications. BMC Nephrology, 16 (1) 89, 1-8. doi: 10.1186/s12882-015-0089-2

The omega-3 fatty acids (fish oils) and aspirin in Vascular access outcomes in renal disease (FAVOURED) study: the updated final trial protocol and rationale of post-initiation trial modifications

2015

Journal Article

Left ventricular global longitudinal strain (GLS) is a superior predictor of all-cause and cardiovascular mortality when compared to ejection fraction in advanced chronic kidney disease

Krishnasamy, Rathika, Isbel, Nicole M., Hawley, Carmel M., Pascoe, Elaine M., Burrage, Matthew, Leano, Rodel, Haluska, Brain A., Marwick, Thomas H. and Stanton, Tony (2015). Left ventricular global longitudinal strain (GLS) is a superior predictor of all-cause and cardiovascular mortality when compared to ejection fraction in advanced chronic kidney disease. PLoS ONE, 10 (5) 0127044, 1-15. doi: 10.1371/journal.pone.0127044

Left ventricular global longitudinal strain (GLS) is a superior predictor of all-cause and cardiovascular mortality when compared to ejection fraction in advanced chronic kidney disease

2015

Journal Article

N-terminal pro-B-type natriuretic peptide variability in stable dialysis patients

Fahim, Magid A, Hayen, Andrew, Horvath, Andrea R, Dimeski, Goce, Coburn, Amanda, Johnson, David W, Hawley, Carmel M, Campbell, Scott B and Craig, Jonathan C (2015). N-terminal pro-B-type natriuretic peptide variability in stable dialysis patients. Clinical Journal of the American Society of Nephrology, 10 (4), 620-629. doi: 10.2215/CJN.09060914

N-terminal pro-B-type natriuretic peptide variability in stable dialysis patients

2015

Journal Article

Biological variation of high sensitivity cardiac troponin-T in stable dialysis patients: implications for clinical practice

Fahim, Magid A., Hayen, Andrew D., Horvath, Andrea R., Dimeski, Goce, Coburn, Amanda, Tan, Ken-Soon, Johnson, David W., Craig, Jonathan C., Campbell, Scott B. and Hawley, Carmel M. (2015). Biological variation of high sensitivity cardiac troponin-T in stable dialysis patients: implications for clinical practice. Clinical Chemistry and Laboratory Medicine, 53 (5), 715-722. doi: 10.1515/cclm-2014-0838

Biological variation of high sensitivity cardiac troponin-T in stable dialysis patients: implications for clinical practice

2015

Journal Article

Utility of urinary biomarkers in predicting loss of residual renal function: the balANZ trial

Cho, Yeoungjee, Johnson, David W., Vesey, David A., Hawley, Carmel M., Clarke, Margaret and Topley, Nicholas (2015). Utility of urinary biomarkers in predicting loss of residual renal function: the balANZ trial. Peritoneal Dialysis International, 35 (2), 159-171. doi: 10.3747/pdi.2013.00170

Utility of urinary biomarkers in predicting loss of residual renal function: the balANZ trial

2015

Journal Article

The rationale and design of the beta-blocker to LOwer CArdiovascular Dialysis Events (BLOCADE) feasibility study

Roberts, Matthew A., Pilmore, Helen L., Ierino, Francesco L., Badve, Sunil V., Cass, Alan, Garg, Amit X., Hawley, Carmel M., Isbel, Nicole M., Krum, Henry, Pascoe, Elaine M., Tonkin, Andrew M., Vergara, Liza A., Perkovic, Vlado and The BLOCADE Study Collaborative Group (2015). The rationale and design of the beta-blocker to LOwer CArdiovascular Dialysis Events (BLOCADE) feasibility study. Nephrology, 20 (3), 140-147. doi: 10.1111/nep.12362

The rationale and design of the beta-blocker to LOwer CArdiovascular Dialysis Events (BLOCADE) feasibility study

2015

Journal Article

The role of monitoring vancomycin levels in patients with peritoneal dialysis-associated peritonitis

Stevenson, Sarah, Tang, Wen, Cho, Yeoungjee, Mudge, David W., Hawley, Carmel M., Badve, Sunil V. and Johnson, David W. (2015). The role of monitoring vancomycin levels in patients with peritoneal dialysis-associated peritonitis. Peritoneal Dialysis International, 35 (2), 222-228. doi: 10.3747/pdi.2013.00156

The role of monitoring vancomycin levels in patients with peritoneal dialysis-associated peritonitis

2015

Journal Article

Outcomes of integrated home dialysis care: a multi-centre, multi-national registry study

Nadeau-Fredette, Annie-Claire, Chan, Christopher T., Cho, Yeoungjee, Hawley, Carmel M., Pascoe, Elaine M., Clayton, Philip A., Polkinghorne, Kevan R., Boudville, Neil, Leblanc, Martine and Johnson, David W. (2015). Outcomes of integrated home dialysis care: a multi-centre, multi-national registry study. Nephrology Dialysis Transplantation, 30 (11), 1897-1904. doi: 10.1093/ndt/gfv132

Outcomes of integrated home dialysis care: a multi-centre, multi-national registry study

2015

Journal Article

End-Stage kidney disease due to fibrillary glomerulonephritis and immunotactoid glomerulopathy - outcomes in 66 consecutive ANZDATA registry cases

Mallett, Andrew, Tang, Wen, Hart, Gareth, McDonald, Stephen P., Hawley, Carmel M., Badve, Sunil V., Boudville, Neil, Brown, Fiona G., Campbell, Scott B., Clayton, Philip A. and Johnson, David W. (2015). End-Stage kidney disease due to fibrillary glomerulonephritis and immunotactoid glomerulopathy - outcomes in 66 consecutive ANZDATA registry cases. American Journal of Nephrology, 42 (3), 177-184. doi: 10.1159/000440815

End-Stage kidney disease due to fibrillary glomerulonephritis and immunotactoid glomerulopathy - outcomes in 66 consecutive ANZDATA registry cases

2015

Conference Publication

Outcomes of Integrated Home Dialysis Care: a Multi-Centre Registry Study

Nadeau-Fredette, Annie-Claire, Chan, Christopher T., Cho, Yeoungjee, Hawley, Carmel, Pascoe, Elaine, Clayton, Philip A., Leblanc, Martine, Boudville, Neil, Polkinghorne, Kevan R. and Johnson, David W. (2015). Outcomes of Integrated Home Dialysis Care: a Multi-Centre Registry Study. 52nd Congress of the European Renal Association European Dialysis and Transplant Assocation, London, United Kingdom, 28-31 May 2015. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/ndt/gfv180.10

Outcomes of Integrated Home Dialysis Care: a Multi-Centre Registry Study

2015

Conference Publication

FP556 Predictors of transfer to home hemodialysis after definitive peritoneal dialysis completion

Nadeau-Fredette, Annie-Claire, Chan, Christopher T, Hawley, Carmel, Pascoe, Elaine, Leblanc, Martine, Clayton, Philip A, Polkinghorneghorne, Kevan R, Boudville, Neil and Johnson, David W. (2015). FP556 Predictors of transfer to home hemodialysis after definitive peritoneal dialysis completion. 52nd ERA-EDTA Congress, London, United Kingdom, 28th-31st May 2015. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/ndt/gfv180.08

FP556 Predictors of transfer to home hemodialysis after definitive peritoneal dialysis completion

2015

Journal Article

A randomized, placebo-controlled trial of pentoxifylline on erythropoiesis-stimulating agent hyporesponsiveness in anemic patients with CKD: the handling erythropoietin resistance with oxpentifylline (HERO) trial

Johnson, David W., Pascoe, Elaine M., Badve, Sunil V., Dalziel, Kim, Cass, Alan, Clarke, Philip, Ferrari, Paolo, McDonald, Stephen P., Morrish, Alicia T., Pedagogos, Eugenie, Perkovic, Vlado, Reidlinger, Donna, Scaria, Anish, Walker, Rowan, Vergara, Liza A., Hawley, Carmel M., on behalf of the HERO Study Collaborative Group and Fassett, Rob (2015). A randomized, placebo-controlled trial of pentoxifylline on erythropoiesis-stimulating agent hyporesponsiveness in anemic patients with CKD: the handling erythropoietin resistance with oxpentifylline (HERO) trial. American Journal of Kidney Diseases, 65 (1), 49-57. doi: 10.1053/j.ajkd.2014.06.020

A randomized, placebo-controlled trial of pentoxifylline on erythropoiesis-stimulating agent hyporesponsiveness in anemic patients with CKD: the handling erythropoietin resistance with oxpentifylline (HERO) trial

2015

Conference Publication

Scope and consistency of outcomes reported in randomised trials of haemodialysis

Williams, G. J., Tong, A., Manns, B., Hemmelgarn, B., Wheeler, D. C., Tugwell, P., Winkelmayer, W. C., Van Biesen, W., Kerr, P. G., Polkinghorne, K. R., Howard, K., Pollock, C., Hawley, C. M., Johnson, D. W., Mcdonald, S. P., Gallagher, M. P., Urquhart-Secord, R. and Craig, J. C. (2015). Scope and consistency of outcomes reported in randomised trials of haemodialysis. 51st Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Canberra, ACT Australia, 7-9 September 2015. HOBOKEN: WILEY-BLACKWELL.

Scope and consistency of outcomes reported in randomised trials of haemodialysis

2015

Conference Publication

Association between left ventricular global longitudinal strain, functional capacity and quality of life in patients with chronic kidney disease

Stanton, Tony, Krishnasamy, Rathika, Hawley, Carmel M., Howden, Erin, Beetham, Kassia, Strand, Haakan, Leano, Rodel L., Haluska, Brian A., Coombes, Jeff S. and Isbel, Nicole M. (2015). Association between left ventricular global longitudinal strain, functional capacity and quality of life in patients with chronic kidney disease. Cardiac Society of Australia and New Zealand Annual Scientific Meeting and the International Society for Heart Research Australasian Section Annual Scientific Meeting, Melbourne, VIC, Australia, 13-16 August 2015. Chatswood, NSW Australia: Elsevier Australia. doi: 10.1016/j.hlc.2015.06.502

Association between left ventricular global longitudinal strain, functional capacity and quality of life in patients with chronic kidney disease

2015

Conference Publication

Chronic kidney disease is associated with progressive increase in arterial stiffness and bone-muscle loss over 1 year

Krishnasamy, R., Isbel, N. M., Johnson, D. W., Stanton, T., Fiumara, F., Bolwell, J., Vaneps, C., Mudge, D. W., Campbell, S., Tan, S. J., Toussaint, N. D. and Hawley, C. M. (2015). Chronic kidney disease is associated with progressive increase in arterial stiffness and bone-muscle loss over 1 year. 51st Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Canberra, Australia, 7-9 September 2015. Richmond, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/nep.12543

Chronic kidney disease is associated with progressive increase in arterial stiffness and bone-muscle loss over 1 year

2015

Conference Publication

Predictors of Transfer to Home Hemodialysis After Definitive Peritoneal Dialysis Completion

Nadeau-Fredette, Annie-Claire, Chan, Christopher T., Hawley, Carmel, Pascoe, Elaine, Leblanc, Martine, Clayton, Philip A., Polkinghorneghorne, Kevan R., Boudville, Neil and Johnson, David W. (2015). Predictors of Transfer to Home Hemodialysis After Definitive Peritoneal Dialysis Completion. 52nd Congress of the European-Renal-Association-European-Dialysis-and-Transplant-Assocation, London England, May 28-31, 2015. OXFORD: Wiley-Blackwell. doi: 10.1093/ndt/gfv180.8

Predictors of Transfer to Home Hemodialysis After Definitive Peritoneal Dialysis Completion

Current funding

  • 2024 - 2029
    A multi-centre randomised controlled trial to treat acute T-cell mediated rejection in kidney and kidney pancreas transplant recipients (TACKLE-IT trial) (USyd administered MRFF ICTC 2023 grant)
    University of Sydney
    Open grant
  • 2024 - 2029
    A randomised trial of intensive vs less intensive corticosteroids for children with nephrotic syndrome (OPEN trial) (Administered by Flinders University)
    Flinders University
    Open grant
  • 2021 - 2026
    Centre of Research Excellence: Partnering with patients with chronic kidney disease to transform care and outcomes (CRE-PACT) (administered by University of Sydney)
    University of Sydney
    Open grant

Past funding

  • 2021 - 2023
    Patient perspectives and involvement in co-design of a trial evaluating interventions to improve gut health in peritoneal dialysis - GUT PD Study (ISPD grant led by Eastern Institute of Technology)
    Eastern Institute of Technology
    Open grant
  • 2021 - 2024
    Better Evidence and Translation In Chronic Kidney Disease (BEAT-CKD) (administered by SAHMRI)
    South Australian Health and Medical Research Institute Limited
    Open grant
  • 2020 - 2024
    BEAT-Calci (Better Evidence And Translation in Calciphylaxis) (MRFF RCRDUN administered by University of Sydney)
    University of Sydney
    Open grant
  • 2020 - 2024
    Vascular Access outcome measure for function: a vaLidation study In haemoDialysis (VALID)
    Metro South Hospital and Health Service
    Open grant
  • 2020 - 2025
    Serum phosphate to improve outcomes for dialysis patients: The PHOSPHATE Trial (HRC New Zealand)
    University of Otago
    Open grant
  • 2019 - 2025
    Better health through better trials: A national network to develop and implement innovative clinical trials methodology (NHMRC CRE administered by Monash University)
    Monash University
    Open grant
  • 2019 - 2024
    NAVKIDS2 trial: a multi-centre, dynamic, waitlist randomized controlled trial of patient navigators in children with chronic kidney disease (MRFF RCRDUN administered by University of Sydney)
    University of Sydney
    Open grant
  • 2019 - 2021
    A Targeted Education ApproaCH to improve Peritoneal Dialysis outcomes - Cluster Randomised Controlled Trial (MSH Research Support Scheme Project Grant administered by MSHHS)
    Metro South Hospital and Health Service
    Open grant
  • 2018 - 2020
    IMPEDE-PKD (Implementation of Metformin therapy to Ease Decline of kidney function in PKD). A Clinical Trial Investigating Metformin to slow the progression of renal dysfunction in ADPKD
    PKD Foundation of Australia Limited
    Open grant
  • 2018 - 2024
    Better Evidence for Selecting Transplant Fluids: The BEST-Fluids Trial (MRFF LCTRC administered by University of Sydney)
    University of Sydney
    Open grant
  • 2017 - 2022
    Evaluation of the efficacy and safety of health service dialysate sodium practice on clinical outcomes (NHMRC Project Grant externally led by the University of Sydney)
    University of New South Wales
    Open grant
  • 2016 - 2021
    Mid Cut-Off Haemodialysis: a safety and efficacy study
    Baxter Healthcare Pty Ltd
    Open grant
  • 2016
    The BLOCADE Study
    Austin Medical Research Foundation
    Open grant
  • 2016 - 2019
    Pexivas - NIHR
    Cambridge University Hospitals NHS Foundation Trust
    Open grant
  • 2016
    The TECH-PD trial (pilot study)
    International Society of Peritoneal Dialysis
    Open grant
  • 2016 - 2021
    Better evidence, better care and outcomes for people with chronic kidney disease (NHMRC Program Grant administered by Flinders University)
    Flinders University
    Open grant
  • 2014 - 2019
    KHA Operations Support
    Kidney Health Australia
    Open grant
  • 2014 - 2017
    ANZSN Operations Support
    Australian and New Zealand Society of Nephrology
    Open grant
  • 2013 - 2018
    A randomised, double-blind, placebo-controlled trial to assess the effect of phosphate reduction with lanthanum carbonate on arterial compliance and vascular calcification in patients with chronic kid
    NHMRC Project Grant
    Open grant
  • 2013 - 2015
    FAVOURED Trial
    AMGEN Australia Pty. Ltd.
    Open grant
  • 2013
    IMPROVE: IMPROVE (IMpact of Phospate Reduction on Vascular Endpoints in Chronic Kidney Disease)
    PA Research Foundation
    Open grant
  • 2012 - 2013
    The utility of matrix metalloproteinase-2 (MMP-2) to predict peritoneal injury in the incident PD population
    Kidney Health Australia
    Open grant
  • 2012 - 2014
    Serial NT-proBNP Monitoring for Predicting Major Cardiovascular Events in the Dialysis Population
    NHMRC Project Grant
    Open grant
  • 2011 - 2013
    AVATAR: ACE Inhibition for the preservation of renal function and patient survival in kidney transplantation (Canadian Institutes of Health Research grant admin. by the Ottawa Hospital Research Inst.)
    Ottawa Hospital Research Institute
    Open grant
  • 2011 - 2015
    The Beta-blocker to Lower Cardiovascular Dialysis Events (BLOCADE) Feasibility Study (NHMRC Project Grant administered by Uni Melbourne)
    University of Melbourne
    Open grant
  • 2011 - 2012
    The Utility of Serial NT-proBNP Monitoring for Predicting Cardiac Outcomes in the Dialysis Population
    Kidney Health Australia
    Open grant
  • 2010 - 2017
    PEXIVAS: Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis (NHMRC Project Grant administered by the University of Adelaide)
    Central Adelaide Local Health Network Incorporated, trading as Royal Adelaide Hospital
    Open grant
  • 2010 - 2016
    Favoured: fish oil and aspirin in vascular access outcomes in renal disease
    Abbott Products Operations AG
    Open grant
  • 2010 - 2020
    IMPROVE: IMpact of Phosphate Reduction On Vascular Endpoints in chronic kidney disease
    Shire
    Open grant
  • 2008 - 2013
    A randomised controlled trial of exit site application of Medihoney(TM) for the prevention of catheter associated infections in peritoneal dialysis patients
    Queensland Health Smart Health Research Grant
    Open grant
  • 2008 - 2011
    A randomised, placebo-controlled trial of oxpentifylline on haemoglobin levels in patients with erythropoietin-resistant anaemia
    AMGEN Australia Pty. Ltd.
    Open grant
  • 2007 - 2010
    HERO (A randomized, placebo-controlled trial of oxpentifylline on haemoglobin levels in patients with erythropoietin-resistant anaemia)
    Janssen-Cilag Pty Limited (Janssen-Cilag Australia)
    Open grant
  • 2007 - 2012
    A randomised placebo-controlled trial of Oxpentifylline (Trental) in erythropoietin-resistant anaemia (ERA) in chronic kidney disease
    The Roche Foundation for Anemia Research
    Open grant
  • 2007 - 2014
    A trial of aspirin and fish oil for the prevention of thrombosis in dialysis access
    University of Western Australia
    Open grant
  • 2005 - 2016
    Australasian Kidney Trials Network (AKTN)
    NHMRC Enabling Grant
    Open grant
  • 2005 - 2011
    Australasian Clinical Trials Network in Nephrology (CTNN)
    Australian Kidney Foundation
    Open grant
  • 2005 - 2011
    Australialian Kidney Trials (AKT) Network
    Australian and New Zealand Society of Nephrology
    Open grant

Availability

Professor Carmel Hawley is:
Available for supervision

Looking for a supervisor? Read our advice on how to choose a supervisor.

Supervision history

Current supervision

Completed supervision

Enquiries

Contact Professor Carmel Hawley directly for media enquiries about:

  • Chronic Kidney Disease
  • Haemodialysis
  • Kidney Clinical Trials
  • Kidney Dialysis
  • Kidney Transplant
  • Nephrology
  • Peritoneal Dialysis

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au